Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trial.

Differences between groups were nominally significant (nominal P < 0.05) if the 95% confidence interval [CI] of the group difference did not include the null value (0 for mean differences and 1 for odds ratios), but for the sake of convenience, if the nominal P ‐value in the secondary analysis is less than 0.05, it is described as significant, and if it is 0.05 or more, it is described as non‐significant.

also in 7,414 other papers